Tyche Industries (TYCHE) | Financial Analysis & Statements
Tyche Industries Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
127.0M
Gross Profit
87.5M
68.87%
Operating Income
14.9M
11.77%
Net Income
24.3M
19.15%
EPS (Diluted)
₹2.37
Balance Sheet Metrics
Total Assets
1.5B
Total Liabilities
107.1M
Shareholders Equity
1.4B
Debt to Equity
0.08
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Tyche Industries Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 654.7M | 695.1M | 753.9M | 622.7M | 782.4M |
| Cost of Goods Sold | 364.0M | 410.5M | 433.8M | 367.2M | 395.3M |
| Gross Profit | 290.7M | 284.6M | 320.0M | 255.4M | 387.1M |
| Gross Margin % | 44.4% | 40.9% | 42.5% | 41.0% | 49.5% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 66.2M | 45.7M | 50.3M | 50.6M | 40.4M |
| Other Operating Expenses | 11.2M | 13.9M | 14.0M | 11.2M | 7.6M |
| Total Operating Expenses | 77.3M | 59.6M | 64.2M | 61.8M | 48.0M |
| Operating Income | 100.3M | 108.8M | 145.9M | 99.0M | 241.5M |
| Operating Margin % | 15.3% | 15.7% | 19.4% | 15.9% | 30.9% |
| Non-Operating Items | |||||
| Interest Income | 60.4M | 50.5M | 36.9M | 30.4M | 29.2M |
| Interest Expense | 0 | 0 | 0 | 0 | 69.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 167.1M | 166.3M | 190.8M | 126.4M | 267.3M |
| Income Tax | 43.1M | 43.9M | 49.1M | 33.0M | 67.5M |
| Effective Tax Rate % | 25.8% | 26.4% | 25.7% | 26.2% | 25.3% |
| Net Income | 124.1M | 122.4M | 141.7M | 93.3M | 199.8M |
| Net Margin % | 19.0% | 17.6% | 18.8% | 15.0% | 25.5% |
| Key Metrics | |||||
| EBITDA | 186.8M | 185.7M | 209.8M | 123.4M | 294.5M |
| EPS (Basic) | ₹12.20 | ₹11.95 | ₹13.83 | ₹9.11 | ₹19.51 |
| EPS (Diluted) | ₹12.20 | ₹11.95 | ₹13.83 | ₹9.11 | ₹19.51 |
| Basic Shares Outstanding | 10245000 | 10245000 | 10245000 | 10245000 | 10245000 |
| Diluted Shares Outstanding | 10245000 | 10245000 | 10245000 | 10245000 | 10245000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Tyche Industries Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 39.8M | 39.7M | 67.2M | 35.9M | 73.0M |
| Short-term Investments | 772.2M | 718.0M | 625.7M | 621.9M | 522.8M |
| Accounts Receivable | 171.2M | 191.2M | 220.8M | 164.2M | 171.3M |
| Inventory | 166.4M | 125.6M | 179.7M | 112.4M | 109.5M |
| Other Current Assets | 1.0K | 1.0K | 71.2M | 1.0K | -1.0K |
| Total Current Assets | 1.2B | 1.1B | 1.1B | 1.0B | 963.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 68.2M | 63.8M | 53.6M | 53.2M | 51.4M |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 2.0K | 20.0M | 2.7M | -18.6M | 99.0K |
| Total Non-Current Assets | 264.7M | 238.5M | 242.7M | 192.4M | 206.3M |
| Total Assets | 1.5B | 1.4B | 1.4B | 1.2B | 1.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 58.0M | 38.3M | 123.8M | 59.0M | 68.8M |
| Short-term Debt | 0 | 0 | 0 | 0 | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.0K | 9.7M | 1.0K | 21.1M | 17.8M |
| Total Current Liabilities | 96.2M | 66.8M | 165.7M | 128.3M | 177.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 10.8M | 11.7M | 12.4M | 13.6M | 14.5M |
| Other Non-Current Liabilities | -2.0K | - | 1.0K | 18.6M | 17.5M |
| Total Non-Current Liabilities | 10.8M | 34.8M | 33.9M | 32.2M | 32.0M |
| Total Liabilities | 107.1M | 101.6M | 199.6M | 160.5M | 209.9M |
| Equity | |||||
| Common Stock | 102.5M | 102.5M | 102.5M | 102.5M | 102.5M |
| Retained Earnings | 1.2B | 1.1B | 994.2M | 870.8M | 791.9M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.4B | 1.3B | 1.2B | 1.0B | 959.6M |
| Key Metrics | |||||
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Working Capital | 1.1B | 1.1B | 958.7M | 882.0M | 785.3M |
Balance Sheet Composition
Tyche Industries Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 168.2M | 163.9M | 189.5M | 127.3M | 265.3M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 5.2M | 43.5M | -130.0M | 21.6M | -51.5M |
| Operating Cash Flow | 113.0M | 157.0M | 22.5M | 118.5M | 184.6M |
| Investing Activities | |||||
| Capital Expenditures | -7.2M | -32.3M | -17.5M | -9.9M | -25.0M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -59.6M | - | -50.7M | - | - |
| Investment Sales | - | 21.2M | - | - | - |
| Investing Cash Flow | -66.6M | -11.1M | -68.2M | 1.2M | -25.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -25.6M | -20.5M | -15.4M | -10.2M | -10.2M |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | -25.6M | -20.5M | -30.7M | -20.5M | -20.5M |
| Free Cash Flow | 78.2M | 44.8M | 46.8M | 34.7M | 129.5M |
| Net Change in Cash | 20.7M | 125.4M | -76.4M | 99.2M | 139.1M |
Cash Flow Trend
Tyche Industries Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
18.41
Forward P/E
21.18
Price to Book
0.89
Price to Sales
2.48
PEG Ratio
-0.30
Profitability Ratios
Profit Margin
13.29%
Operating Margin
5.74%
Return on Equity
9.08%
Return on Assets
8.42%
Financial Health
Current Ratio
5.29
Debt to Equity
0.00
Beta
0.29
Per Share Data
EPS (TTM)
₹6.65
Book Value per Share
₹137.61
Revenue per Share
₹49.35
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TYCHE | 1.3B | 18.41 | 0.89 | 9.08% | 13.29% | 0.00 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.




